Abstract Early diagnosis of Alzheimer's disease (AD) plays a key role in preventing and responding to this neurodegenerative disease. It has shown that, compared with a single imaging modality‐based classification of AD, synergy exploration among multimodal neuroimages is beneficial for the pathological identification. However, effectively exploiting multimodal information is still a big challenge due to the lack of efficient fusion methods. Herein, a multimodal fusion network based on attention mechanism is proposed, in which magnetic resonance imaging (MRI) and positron emission computed tomography (PET) images are converted into feature vectors with the same dimension, while the demographic information and clinical data are preprocessed ...
Multimodal learning is widely used in automated early diagnosis of Alzheimer's disease. However, the...
Alzheimer’s disease (AD), the most common cause of dementia, affects more than 520,000 people in the...
Automated methods for Alzheimer's disease (AD) classification have the potential for great clinical ...
Alzheimer’s disease (AD) is a neurological disease that affects numerous people. The condition cause...
Alzheimer’s disease (AD) is one of the most common neurodegenerative disorders among the elderly pop...
This paper presents a multi-modal Alzheimer's disease (AD) classification framework based on a convo...
Abstract Most current Alzheimer’s disease (AD) and mild cognitive disorders (MCI) studies use single...
In recent years, deep learning models have been applied to neuroimaging data for early diagnosis of ...
Alzheimer's disease is one of the diseases that mostly affects older people without being a part of ...
The accurate diagnosis of Alzheimer's disease (AD) is essential for patient care and will be increas...
Alzheimer’s disease (AD) is a neurodegenerative disease that affects brain cells, and mild cognitive...
Alzheimer's disease (AD) is a complex neurodegenerative disease involving a variety of pathogenic fa...
Alzheimer's Disease (AD) is a progressive neurodegenerative disease where biomarkers for disease bas...
Alzheimer’s Disease (AD) is a progressive neurodegenerative disease where biomarkers for disease bas...
Alzheimer’s disease (AD) is a neurodegenerative disease that affects a large number of people across...
Multimodal learning is widely used in automated early diagnosis of Alzheimer's disease. However, the...
Alzheimer’s disease (AD), the most common cause of dementia, affects more than 520,000 people in the...
Automated methods for Alzheimer's disease (AD) classification have the potential for great clinical ...
Alzheimer’s disease (AD) is a neurological disease that affects numerous people. The condition cause...
Alzheimer’s disease (AD) is one of the most common neurodegenerative disorders among the elderly pop...
This paper presents a multi-modal Alzheimer's disease (AD) classification framework based on a convo...
Abstract Most current Alzheimer’s disease (AD) and mild cognitive disorders (MCI) studies use single...
In recent years, deep learning models have been applied to neuroimaging data for early diagnosis of ...
Alzheimer's disease is one of the diseases that mostly affects older people without being a part of ...
The accurate diagnosis of Alzheimer's disease (AD) is essential for patient care and will be increas...
Alzheimer’s disease (AD) is a neurodegenerative disease that affects brain cells, and mild cognitive...
Alzheimer's disease (AD) is a complex neurodegenerative disease involving a variety of pathogenic fa...
Alzheimer's Disease (AD) is a progressive neurodegenerative disease where biomarkers for disease bas...
Alzheimer’s Disease (AD) is a progressive neurodegenerative disease where biomarkers for disease bas...
Alzheimer’s disease (AD) is a neurodegenerative disease that affects a large number of people across...
Multimodal learning is widely used in automated early diagnosis of Alzheimer's disease. However, the...
Alzheimer’s disease (AD), the most common cause of dementia, affects more than 520,000 people in the...
Automated methods for Alzheimer's disease (AD) classification have the potential for great clinical ...